유전체 맞춤의학 연구와 위험의 개념 이해
The Concept of Risk in the era of Personalized Genetic Medicine
0
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Personalized genetic medicine(PGM) is an attempt to understand the relationship between human genetic information and diseases, and to find a potential treatment and diagnostic method. Large research projects are under way with social concerns. ELSI research is aimed at understanding the implication of an innovative research from humanistic perspectives, and communicating the understanding with society and with scientists, thereby providing practical and concrete recommendations and guides. Of the ELSI studies, ethics of PGM research searches the value problems embedded in various perspectives on PGM and tries to answer the question whether it is permissible to implement certain types of research. A framework for ethical analysis is proposed and explained. The concept of risk in general was explored and its implication for ethical review of PGM in relation with the natures of PGM was given. The risks can be categorized: risks associated with the inherent characteristics of research/practice, risks associated with human eras and risks related social construction and (in)justice. Understanding the nature of risk will help the IRB’s reviewing the PGM researches.
Abstract
Personalized genetic medicine(PGM) is an attempt to understand the relationship between human genetic information and diseases, and to find a potential treatment and diagnostic method. Large research projects are under way with social concerns. ELSI research is aimed at understanding the implication of an innovative research from humanistic perspectives, and communicating the understanding with society and with scientists, thereby providing practical and concrete recommendations and guides. Of the ELSI studies, ethics of PGM research searches the value problems embedded in various perspectives on PGM and tries to answer the question whether it is permissible to implement certain types of research. A framework for ethical analysis is proposed and explained. The concept of risk in general was explored and its implication for ethical review of PGM in relation with the natures of PGM was given. The risks can be categorized: risks associated with the inherent characteristics of research/practice, risks associated with human eras and risks related social construction and (in)justice. Understanding the nature of risk will help the IRB’s reviewing the PGM researches.
참고문헌 (12)
- H. Zwart, "ELSA Research in Europe: Lessons from CSG", International Symposium: Developing Frameworks for ELSI Research on Personalized Medicine 자료집 (2012), Asian Institute for Bioethics and Health Law
- I. Lee, "Framework for Ethical Analysis of ELSI Issues in Genomics and Personalized Medicine", International Symposium: Developing Frameworks for ELSI Research on Personalized Medicine 자료집 (2012), Asian Institute for Bioethics and Health Law
- M.Dunn, "Toward Methodological innovation in Empirical Ethics Reserach, Camb", Quart. Healthc. Ethics, 21(4), pp.466~480 (2012)
- "The Nuremberg Code" (2005)[URL]
- 이일학, "의학 연구에서 위험성 평가: 기관생명윤리심의위원회의 평가를 위해 고려할 사항들", 생명윤리정책연구, 2(3), pp.215~230 (2008)
- Donald M. Bruce, "Social Contract for Biotechnology: Shared Visions for Risk Technology?", Journal of Agricultural and Environmental Ethics, 15(2), pp.279~ (2002)
- Jonathan Wolff, "Risk, Fear, Blame and Shame: The Regulation of Public Safety", Economics and Philosophy, 22, pp.409~ (2006)
- "The Gemonics and Personalized Medicine Act", ~ (2010)
- "미국 국립보건원 유전체 관련성 연구(Genom-wide Association Studies, GWAS)"[URL]
- D. Resnik, "The Ethics of Science: An Introduction", pp.147~171 (1998), Routledge
